Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01869959
What this trial is testing

LY2405319 in Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 47
Early research (Phase 1)Study completedNCT02209766
What this trial is testing

A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)

Who this might be right for
Healthy
AstraZeneca 86
Early research (Phase 1)UnknownNCT06437951
What this trial is testing

To Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection

Who this might be right for
Erosive Gastroesophageal Reflux Disease
Daewoong Pharmaceutical Co. LTD. 40
Early research (Phase 1)Study completedNCT04277910
What this trial is testing

A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004

Who this might be right for
Healthy
Xi'an Biocare Pharma Ltd. 88
Early research (Phase 1)Study completedNCT02739373
What this trial is testing

Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of BMS-986189 in Healthy Subjects

Who this might be right for
Severe Sepsis
Bristol-Myers Squibb 76
Early research (Phase 1)Looking for participantsNCT06804824
What this trial is testing

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Vividion Therapeutics, Inc. 220
Early research (Phase 1)Ended earlyNCT02083666
What this trial is testing

Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration

Who this might be right for
Healthy
Swedish Orphan Biovitrum 24
Very early researchLooking for participantsNCT05145361
What this trial is testing

Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)

Who this might be right for
NMO Spectrum Disorder
Shanghai Pharmaceuticals Holding Co., Ltd 45
Early research (Phase 1)Study completedNCT00416546
What this trial is testing

Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects

Who this might be right for
Healthy
Novartis 96
Early research (Phase 1)Study completedNCT04838405
What this trial is testing

CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes
Carmot Therapeutics, Inc. 129
Early research (Phase 1)Study completedNCT04815551
What this trial is testing

AV-380 in Healthy Subjects

Who this might be right for
Cachexia
AVEO Pharmaceuticals, Inc. 51
Early research (Phase 1)Study completedNCT02254070
What this trial is testing

Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment

Who this might be right for
Healthy
Boehringer Ingelheim 23
Testing effectiveness (Phase 2)Looking for participantsNCT05867251
What this trial is testing

Study of AVZO-021 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorHR+/HER2- Breast CancerHR+, HER2-, Advanced Breast Cancer+6 more
Avenzo Therapeutics, Inc. 430
Early research (Phase 1)Study completedNCT02028780
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 80
Early research (Phase 1)Study completedNCT03708146
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058

Who this might be right for
Cardiovascular Disease+Pulmonary DiseasePulmonary Arterial Hypertension
Bial - Portela C S.A. 157
Early research (Phase 1)Study completedNCT03334851
What this trial is testing

Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis

Who this might be right for
Systemic Lupus ErythematosusRheumatoid Arthritis
Pfizer 74
Early research (Phase 1)Active Not RecruitingNCT07223216
What this trial is testing

Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants

Who this might be right for
Obesity
Biomea Fusion Inc. 80
Early research (Phase 1)Study completedNCT02230878
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42847922 in Healthy Participants

Who this might be right for
Healthy
Janssen-Cilag International NV 40
Early research (Phase 1)Study completedNCT03550950
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-64232025 in Healthy Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 48
Early research (Phase 1)Study completedNCT01944735
What this trial is testing

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Celtaxsys, Inc. 17
Next Page